Semen cassiae composition with auxiliary effect of lowering blood lipid

Abstract

The invention discloses a semen cassiae composition with an auxiliary effect of lowering blood lipid. The semen cassiae composition is prepared by carrying out mixed fermentation for two times on thefollowing raw materials in parts by weight: 20 to 50 parts of semen cassiae, 10 to 50 parts of fructus crataegi, 10 to 50 parts of soybean and 10 to 50 parts of rice. The two times of mixed fermentations refer to that the semen cassiae, the fructus crataegi and the soybean are inoculated into bacillus natto according to formula proportions for fermentation, wherein the inoculation amount of the bacillus natto is 8 to 16 percent; the rice and monascus are added into an obtained fermented product for secondary mixed fermentation, wherein the adding amount of the monascus, counted by the weight of the rice, is 5 to 15 percent; finally, the product is obtained. The active components in the semen cassiae composition disclosed by the invention have an obvious synergistic effect, so as to realizepositive and obvious effects of lowering blood lipid on the aspects of reducing endogenous lipid synthesis, promoting the transportation and excretion of the lipid, regulating lipid metabolism and the like; the semen cassiae composition is proved to be safe, non-toxic and harmless by a safety toxicological test.

Description

technical field [0001] The invention belongs to the technical field of health food, and in particular relates to a cassia seed composition with the effect of assisting in lowering blood fat and a preparation method thereof. Background technique [0002] According to statistics, there are about 5 million new hyperlipidemia patients in the world every year, and about 6 million people lose their ability to work and live because of this. In my country, the number of people with dyslipidemia over the age of 18 has reached 160 million, and about 1 in 10 people suffer from hyperlipidemia. Abnormal, the prevalence rate reaches 42.9% among the crowd aged 35-64, and among them, 25 million people suffer from hypertension and hyperlipidemia at the same time. In recent years, the onset of hyperlipidemia tends to be younger, and the risk of abnormal blood lipids to the health of Chinese people has increased to 3-5 times the original. [0003] In humans, dyslipidemia is a major contributor...

AI Technical Summary

Problems solved by technology

At present, lipid-lowering drugs include statins, fibrates, niacin, and bile acid chelating agents. Long-term use of these drugs will bring certain adverse reactions, such as increasing the probability of myopathy and rhabdomyolysis, destroying liver function, and causing mild symptoms. Degree of kidney damage, etc., hinder the long-term use of these drugs